chr11-2445100-T-A
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1PS1_ModeratePM2PP5_Moderate
The NM_000218.3(KCNQ1):c.2T>A(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000218.3 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNQ1 | NM_000218.3 | c.2T>A | p.Met1? | start_lost | Exon 1 of 16 | ENST00000155840.12 | NP_000209.2 | |
KCNQ1 | NM_001406836.1 | c.2T>A | p.Met1? | start_lost | Exon 1 of 15 | NP_001393765.1 | ||
KCNQ1 | NM_001406838.1 | c.2T>A | p.Met1? | start_lost | Exon 1 of 11 | NP_001393767.1 | ||
KCNQ1 | NM_001406837.1 | c.-361T>A | 5_prime_UTR_variant | Exon 1 of 17 | NP_001393766.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.2T>A | p.Met1? | start_lost | Exon 1 of 16 | 1 | NM_000218.3 | ENSP00000155840.2 | ||
KCNQ1 | ENST00000646564.2 | c.2T>A | p.Met1? | start_lost | Exon 1 of 11 | ENSP00000495806.2 | ||||
KCNQ1 | ENST00000496887.7 | c.24-283T>A | intron_variant | Intron 1 of 15 | 5 | ENSP00000434560.2 | ||||
KCNQ1 | ENST00000345015.4 | n.-222T>A | upstream_gene_variant | 1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 936200Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 440548
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Although the c.2 T>A pathogenic variant in the KCNQ1 gene has not been published to our knowledge, another pathogenic variant affecting the same nucleotide, c.2 T>C, has been reported previously in association with JLNS and LQTS (Wang et al., 2011; Gao et al., 2016). Wang et al. (2011) reported c.2 T>C, situated on opposite KCNQ1 alleles (in trans) from a pathogenic frameshift variant, in one individual with JLNS. This individual's father, who was asymptomatic but had a borderline prolonged QTc interval, also harbored c.2 T>C (Wang et al., 2011). Subsequently, Gao et al (2015) identified c.2 T>C in three Chinese individuals with LQTS, and reported it was absent in at least 100 ethnically matched, healthy control alleles. Data from control individuals was not available to assess whether c.2 T>A may be a common benign variant in the general population. Both the c.2 T>A variant and the c.2 T>C variant alter the initiator Methionine residue of KCNQ1. Western blot studies showed that c.2 T>C may cause an alternate translation initiation site downstream and yields a truncated protein that is missing the initial 158 amino acid residues of the KCNQ1 protein (Wang et al., 2011). Additional functional studies showed that while the c.2 T>C variant does not demonstrate a dominant negative effect when co-expressed with wild type protein, it does result in loss of function of the KCNQ1 channel due to a trafficking defect (Wang et al., 2011).In summary, c.2 T>A in the KCNQ1 gene is interpreted as a pathogenic variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at